NHS to Offer Drug for Tuberous Sclerosis Complex

British children suffering from a rare form of genetic disorder now have an alternative to surgery

British children suffering from a rare form of genetic disorder now have an alternative to surgery after the NHS revealed that it will be offering a new drug that promises to reduce the tumor size that occurs in this condition by more than 50 percent.

Known as tuberous sclerosis complex (TSC), the condition affects more than 1,600 children in UK and is responsible for the growth of non-malignant tumors in brain and kidneys. Until now, the only form of treatment has been surgery.

Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.

However the new drug, known as everolimus, has been found to shrink the subependymal giant cell astrocytoma (SEGA) tumors associated with TSC by more than 50 percent. NHS doctors can now apply for funding from the health trusts after the drug was granted orphan drug status for rare diseases.

Source-Medindia

Oral Cancer | Mouth Cancer - Types, Causes, Symptoms, Diagnosis, Treatment & Prevention
Oral cancer is a cancer that develops in any part of the mouth. It is more common in men over 40.

About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.